Chemicals & Advanced Materials Global On demand · 24-48h

Global Harpagophytum Procumbens Extract Market Strategic Research Report

Global Harpagophytum Procumbens Extract Market Strategic Res…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Harpagophytum Procumbens Extract Market
$8.012025
6.7%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: 10∶1, 20∶1, 30∶1

By Application: Food, Medicine, Cosmetic, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Euromed, Indena, IFF, Givaudan Health, Phytoneering Extract Solutions, Finzelberg, MartinBauer, Select Botanical, Natac Group, Bio-Botanica, Afriplex, Botanic’All, Provital, Wellgreen Technology, Shaanxi Sinuote, Shaanxi Tianxingjian Bio-chemical Technology, Shaanxi Yongyuan Bio-Tech

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 132 pages
Market size 2025
$8.01
Million USD
Forecast CAGR
6.7%
2025-2032
Forecast 2032
$12.6
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

Overview

Scope of the Report

The global Harpagophytum Procumbens Extract market size is predicted to grow from US$ 8.01 million in 2025 to US$ 12.62 million in 2032; it is expected to grow at a CAGR of 6.7% from 2026 to 2032.

In 2025, global sales volume of Harpagophytum Procumbens Extract is estimated at approximately 195 tons, with an average global market price of about USD 42/kg. The gross margin of major producers in the industry is generally around 25%-40%.

Harpagophytum Procumbens Extract is a plant extract produced from the roots and secondary tubers of Harpagophytum procumbens, commonly known as devil’s claw, through water extraction, alcohol extraction, concentration and drying processes, with CAS No. 84988-65-8. Its main active components are iridoid glycosides such as harpagoside, and common specifications include ordinary ratio extracts and standardized extracts with specified harpagoside content.

Its upstream mainly includes Harpagophytum procumbens roots and secondary tuber raw materials, extraction solvents such as water and ethanol, excipients such as maltodextrin, concentration and drying equipment, plant extraction equipment, testing instruments and packaging materials. Raw material supply is significantly affected by wild harvesting in southern Africa, sustainable collection practices, origin control and export trade. The midstream covers the production and processing of Harpagophytum Procumbens Extract, mainly including raw material cleaning, crushing, extraction, filtration, concentration, drying, milling, sieving, standardization and quality testing. The downstream mainly serves food, Medicine, cosmetics and other health care fields, among which the food sector is mainly represented by dietary supplements, functional foods and health foods.

Global key Harpagophytum Procumbens Extract players cover Euromed, Indena, IFF, Givaudan Health, Phytoneering Extract Solutions, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Harpagophytum Procumbens Extract market?

What factors are driving Harpagophytum Procumbens Extract market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Harpagophytum Procumbens Extract market opportunities vary by end market size?

How does Harpagophytum Procumbens Extract break out by Type, by Application?

This report presents a comprehensive overview of the global Harpagophytum Procumbens Extract market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • 10∶1
  • 20∶1
  • 30∶1

Segment by Form

  • Powder
  • Granule
  • Liquid

Segment by Extraction Solvent

  • Water Extract Type
  • Alcohol Extract Type

Segment by Application

  • Food
  • Medicine
  • Cosmetic
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Harpagophytum Procumbens Extract market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Food, Medicine, Cosmetic evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Harpagophytum Procumbens Extract Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 6.7%
Regional growth momentum
Market share by segment
Key metrics
Base value
$8.01
2025
Forecast
$12.6
2032
CAGR
6.7%
2025–2032
Regions
5
global
Key companies
EuromedIndenaIFFGivaudan HealthPhytoneering Extract SolutionsFinzelbergMartinBauerSelect Botanical
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
10∶120∶130∶1
By Application
FoodMedicineCosmeticOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 10∶1
  • 3.1.3 20∶1
  • 3.1.4 30∶1
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Food
  • 4.1.3 Medicine
  • 4.1.4 Cosmetic
  • 4.1.5 Other
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Euromed
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Indena
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 IFF
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Givaudan Health
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Phytoneering Extract Solutions
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Finzelberg
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 MartinBauer
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Select Botanical
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Natac Group
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Bio-Botanica
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Afriplex
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Botanic’All
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Provital
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Wellgreen Technology
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Shaanxi Sinuote
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Shaanxi Tianxingjian Bio-chemical Technology
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Shaanxi Yongyuan Bio-Tech
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Harpagophytum Procumbens Extract market?
The global Harpagophytum Procumbens Extract market is estimated at US$ 8.01 million in 2025 (base year) and is projected to reach US$ 12.62 million by 2032.
What is the forecast CAGR for the Harpagophytum Procumbens Extract market?
The market is expected to grow at a CAGR of 6.7% from 2026 to 2032, expanding from US$ 8.01 million in 2025 to US$ 12.62 million in 2032, roughly 1.6 times its base-year value.
What is Harpagophytum Procumbens Extract?
In 2025, global sales volume of Harpagophytum Procumbens Extract is estimated at approximately 195 tons, with an average global market price of about USD 42/kg. The gross margin of major producers in the industry is generally around 25%-40%.
How is the Harpagophytum Procumbens Extract market segmented by type?
By type, the market is segmented into 10∶1, 20∶1 and 30∶1.
What are the key applications of Harpagophytum Procumbens Extract?
Key applications covered include Food, Medicine, Cosmetic and Other.
Which companies are profiled in the Harpagophytum Procumbens Extract market report?
Key players profiled include Euromed, Indena, IFF, Givaudan Health, Phytoneering Extract Solutions, Finzelberg, MartinBauer and Select Botanical, among 17 companies covered in total.
What geographies does the Harpagophytum Procumbens Extract market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Harpagophytum Procumbens Extract?
What factors are driving Harpagophytum Procumbens Extract market growth, globally and by region?
Who should buy the Harpagophytum Procumbens Extract market report?
The report is intended for manufacturers and solution providers, distributors and end users in Food, Medicine and Cosmetic, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Harpagophytum Procumbens Extract market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from $3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.